Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction
PMCID: PMC4404515 ) He L, Wang J, Ping F, Yang N, Huang J, Li Y, Xu L, Li W, Zhang H (2022) Association of glucagon-like peptide-1 receptor agonist use with risk of gallbladder and biliary diseases: a systematic review and meta-analysis of randomized clinical trials
FDA Safety Announcement: Mounjaro FDA Safety Label Change and Revised Drug LabelThe revised drug label contains a complete list of FDA-approved indications, side effects, warnings, and more
You might be the smartest lawyer in town, but if youre not someone we respect and would want to spend time with or have lunch with every day, then you arent right for SMGQ
When metabolism improves, the body's natural hormone systemsincluding GLP-1often function more effectively